Combo Laser Treatment Helps in Leg Telangiectasias

Majority of patients and physicians rate the results as 'very good' and 'good'

MONDAY, Nov. 22 (HealthDay News) -- A novel treatment for leg telangiectasias using sequential pulses from combined long pulsed dye (LPDL) and Nd:YAG lasers produces good results with minimal side effects, according to a clinical report in the November issue of Lasers in Surgery and Medicine.

Mario A. Trelles, M.D., of the Instituto Médico Vilafortuny in Tarragona, Spain, and colleagues treated 60 female patients (aged 24 to 62 years, skin types II to IV) with leg telangiectasias with pulses of 585 nm LPDL and 1064 nm Nd:YAG lasers. The lasers were delivered sequentially using the Cynergy pulse dye laser, which has the dual wavelength lasers incorporated into one console.

The researchers found that, at two months after the initial treatment, 34 patients did not require another treatment and 26 received a second. At six months after the first treatment, 18 patients subjectively scored their results as very good, 22 as good, 14 as fair, and six as poor. Physicians rated the results better (24 very good, 23 good, 11 fair, and two poor), and a computer analysis of photos rated the results slightly higher still (25 very good, 24 good, nine fair, and two poor).

"The combination of LPDL and Nd:YAG laser pulses offered efficient treatment of leg veins irrespective of skin type. Results were better on blue and vessels larger than 1 mm. Side effects were minimal and transient," the authors conclude.

One study author disclosed being a former consultant for Cynosure, which manufactures the dual laser.

Abstract
Full Text (subscription or payment may be required)

Physician's Briefing